Table 2.
Baseline characteristics, and perioperative and postoperative outcomes for the total cohort used in the Achievable Benchmark of Care analysis
| LSPDP (n = 951) |
RSPDP (n = 279) |
P* | |
|---|---|---|---|
| Baseline characteristics | |||
| Age (years), median (i.q.r.) | 59 (46–69) | 57 (44–66) | 0.034† |
| Women | 589 (61.9) | 175 (62.7) | 0.811 |
| ASA fitness grade I–II | 576 (80.9) | 220 (79.4) | 0.599 |
| BMI (kg/m2), median (i.q.r.) | 25.2 (22.3–28.3) | 24.7 (22.1–28.0) | 0.208† |
| Previous abdominal surgery | 333 (36.0) | 114 (40.9) | 0.141 |
| Tumour size > 5 cm | 87 (11.3) | 24 (11.2) | 0.963 |
| Perioperative and postoperative outcomes | |||
| Method of spleen preservation | <0.001 | ||
| Warshaw | 235 (33.0) | 19 (9.7) | |
| Kimura | 477 (67.0) | 176 (90.3) | |
| Duration of operation (min), median (i.q.r.) | 195 (150–254) | 262.5 (210–340) | <0.001† |
| Blood loss (ml), median (i.q.r.) | 100 (50–250) | 100 (90–200) | 0.590† |
| Conversion | 82 (8.6) | 19 (6.8) | 0.337 |
| Failure to preserve spleen | 180 (18.9) | 44 (15.8) | 0.230 |
| Overall morbidity | 469 (49.4) | 153 (54.8) | 0.108 |
| Major morbidity | 138 (14.6) | 32 (11.5) | 0.187 |
| CR-POPF | 164 (17.3) | 60 (21.5) | 0.108 |
| Duration of hospital stay (days), median (i.q.r.) | 7 (5–10) | 8 (6–11) | <0.001† |
| Readmission within 90 days | 129 (13.8) | 31 (11.2) | 0.264 |
| 90-day mortality | 6 (0.8) | 1 (0.4) | 0.465 |
Values are n (%) unless otherwise indicated. Percentages may not add up owing to rounding and missing data. ASA, American Society of Anaesthesiologists; BMI, body mass index; LSPDP, laparoscopically assisted spleen-preserving distal pancreatectomy; RSPDP, robotically assisted spleen-preserving distal pancreatectomy; CR-POPF, clinically relevant postoperative pancreatic fistula. *χ2 or Fisher’s exact test, except †Mann–Whitney U test.